[1] Weinstein RS. Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity. Bone. 2010;46(3):564-570.
[2] Tan G, Kang PD, Pei FX. Glucocorticoids affect the metabolism of bone marrow stromal cells and lead to osteonecrosis of the femoral head: a review. Chin Med J (Engl). 2012;125(1):134-139.
[3] Bujalska IJ, Kumar S, Hewison M, et al. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology. 1999; 140(7):3188-3196.
[4] Campbell JE, Peckett AJ, D'Souza AM, et al. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am J Physiol Cell Physiol. 2011;300(1):C198-C209.
[5] Lin L, Dai SD, Fan GY. Glucocorticoid-induced differentiation of primary cultured bone marrow mesenchymal cells into adipocytes is antagonized by exogenous Runx2. APMIS. 2010; 118(8):595-605.
[6] Ortiz-Colon G, Grant AC, Doumit ME, et al. Bovine intramuscular, subcutaneous, and perirenal stromal-vascular cells express similar glucocorticoid receptor isoforms, but exhibit different adipogenic capacity. J Anim Sci. 2009;87(6):1913-1920.
[7] Pantoja C, Huff JT, Yamamoto KR. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol Biol Cell. 2008;19(10):4032-4041.
[8] Shi X, Shi W, Li Q, et al. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 2003;4(4):374-380.
[9] Cook JS, Lucas JJ, Sibley E, et al. Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP. Proc Natl Acad Sci U S A. 1988;85(9):2949-2953.
[10] Weinstein RS, O'Brien CA, Almeida M, et al. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. Endocrinology. 2011;152(9):3323-3331.
[11] Eijken, M, Koedam, M, van Driel, M, et al. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol. 2006;248(1-2): 87-93.
[12] Ito S, Suzuki N, Kato S, et al. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone. 2007;40(1):84-92.
[13] Rauch A, Seitz S, Baschant U, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010; 11(6):517-531.
[14] Rodriguez JP, Montecinos L, Rios S, et al. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem. 2000;79(4):557-565.
[15] Derfoul A, Perkins GL, Hall DJ, et al. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells. 2006;24(6):1487-1495.
[16] Wei N, Yu Y, Schmidt T, et al. Effects of glucocorticoid receptor antagonist, RU486, on the proliferative and differentiation capabilities of bone marrow mesenchymal stromal cells in ovariectomized rats. J Orthop Res. 2013;31(5):760-767.
[17] Matsumoto Y, Otsuka F, Takano M, et al. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol Cell Endocrinol. 2010;325(1-2):118-127.
[18] Carcamo-Orive I, Gaztelumendi A, Delgado J, et al. Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk. J Bone Miner Res. 2010;25(10):2115-2125.
[19] Wang J, Gao H, Wang K, et al. Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009;23(7):777-780.
[20] Wang JZ, Gao HY, Wang KZ, et al. Effect of Epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(10):1714-1717.
[21] Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009;18(4):545-559.
[22] Lu H, Guo L, Wozniak MJ, et al. Effect of cell density on adipogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun. 2009;381(3):322-327.
[23] Guo W, Flanagan J, Jasuja R, et al. The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem. 2008;283(14):9136-9145.
[24] Zhang J, Zhang Q, Li S, et al. The effects of Mn(2+) on the proliferation, osteogenic differentiation and adipogenic differentiation of primary mouse bone marrow stromal cells. Biol Trace Elem Res. 2013;151(3):415-423.
[25] You MH, Song MS, Lee SK, et al. Voltage-gated K+ channels in adipogenic differentiation of bone marrow-derived human mesenchymal stem cells. Acta Pharmacol Sin. 2013;34(1): 129-136.
[26] Ciciarello M, Zini R, Rossi L, et al. Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. Stem Cells Dev. 2013;22(7):1097-1111.
[27] Rajalin AM, Pollock H, Aarnisalo P. ERRalpha regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 2010;396(2):477-482.
[28] Lee HL, Woo KM, Ryoo HM, et al. Distal-less homeobox 5 inhibits adipogenic differentiation through the down-regulation of peroxisome proliferator-activated receptor gamma expression. J Cell Physiol. 2013;228(1):87-98.
[29] Chen Y, Liu J, Xu H, et al. Overexpression of the c-Myb but not its leukemogenic mutant DNA-binding domain increased adipogenic differentiation in mesenchymal stem cells. Biochem Biophys Res Commun. 2011;407(1):202-206.
[30] Chiu LH, Yeh TS, Huang HM, et al. Diverse effects of type II collagen on osteogenic and adipogenic differentiation of mesenchymal stem cells. J Cell Physiol. 2012;227(6): 2412-2420.
[31] James AW, Pan A, Chiang M, et al. A new function of Nell-1 protein in repressing adipogenic differentiation. Biochem Biophys Res Commun. 2011;411(1):126-131.
[32] Iwata T, Kawamoto T, Sasabe E, et al. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells. Eur J Cell Biol. 2006;85(5):423-431.
[33] Wang FS, Ko JY, Yeh DW, et al. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology. 2008;149(4):1793-1801.
[34] Wang HY, Ding TL, Xie Y, et al. Osteogenic and adipogenic differentiation of bone marrow-derived mesenchymal stem cells in patients with aplastic anemia. Zhonghua Nei Ke Za Zhi. 2009;48(1):39-43.
[35] Phan TC, Xu J, Zheng MH. Interaction between osteoblast and osteoclast: impact in bone disease. Cell Mol Biol. 2004; (19):1325-1344.
[36] Kerachian MA, Seguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009; 114(3-5):121-128.
[37] Kang P, Pei F, Shen B, et al. Are the results of multiple drilling and alendronate for osteonecrosis of the femoral head better than those of multiple drilling? A pilot study. Joint Bone Spine. 2012;79(1):67-72.
[38] Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50(1):325-330.
[39] 陈炳鹏,常非,王金成,等.髓芯减压联合自体骨髓基质干细胞移植治疗兔激素性股骨头坏死实验研究[J].中国骨与关节损伤杂志, 2010,(1):33-36.
[40] Hang D, Wang Q, Guo C, et al. Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs. Cells Tissues Organs. 2012;195(6):495-506.
[41] Esmail MY, Sun L, Yu L, et al. Effects of PEMF and glucocorticoids on proliferation and differentiation of osteoblasts. Electromagn Biol Med. 2012;31(4):375-381.
[42] Moriya M, Uchiyama K, Takahira N, et al. Evaluation of bipolar hemiarthroplasty for the treatment of steroid-induced osteonecrosis of the femoral head. Int Orthop. 2012;36(10): 2041-2047.
[43] Qi ZX, Kang JD, Li SQ. Effect on transforming growth factor- beta1 of glucocorticoid-induced avascular necrosis of femoral head in rats by treatment of activating blood circulation of Chinese herbal medicine. Zhongguo Gu Shang. 2009;22(8): 596-598.
[44] Erken HY, Ofluoglu O, Aktas M, et al. Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head: experimental study in chicken. Int Orthop. 2012; 36(7):1523-1528.
[45] Kalunian KC, Hahn BH, Bassett L. Magnetic resonance imaging identifies early femoral head ischemic necrosis in patients receiving systemic glucocorticoid therapy. J Rheumatol. 1989;16(7):959-963.
[46] Nakamura J, Ohtori S, Watanabe A, et al. Recovery of the blood flow around the femoral head during early corticosteroid therapy: dynamic magnetic resonance imaging in systemic lupus erythematosus patients. Lupus. 2012;21(3):264-270.
[47] Okazaki S, Nagoya S, Tateda K, et al. Weight bearing does not contribute to the development of osteonecrosis of the femoral head. Int J Exp Pathol. 2012;93(6):458-462.
[48] Qi ZX, Chen L. Effect of Chinese drugs for promoting blood circulation and eliminating blood stasis on vascular endothelial growth factor expression in rabbits with glucocorticoid-induced ischemic necrosis of femoral head. J Tradit Chin Med. 2009;29(2):137-140.
[49] Li Y, Chen J, Zhang Z, et al. The experimental study on treatment of glucocorticoid-induced ischemic necrosis of femoral head by gu fu sheng capsule. J Tradit Chin Med. 2004;24(4):303-307.
[50] He W, Xu C, Fan Y, et al. Effects of the Chinese drugs for activating blood circulation on plasma TXB2 and 6-keto-PGF1 alpha contents in rabbits with glucocorticoid-induced femoral head necrosis. J Tradit Chin Med. 2004;24(3):233-237.
[51] Zhang J, Liu C, Sun J, et al. Effects of water extract of Cajanus cajan leaves on the osteogenic and adipogenic differentiation of mouse primary bone marrow stromal cells and the adipocytic trans-differentiation of mouse primary osteoblasts. Pharm Biol. 2010;48(1):89-95.
[52] 郑立强,徐彬.辛伐他汀治疗早期激素性股骨头坏死的实验研究[J].中国现代医药杂志,2014(3):16-18.
[53] 刘文刚,何伟,许学猛,等.健骨方对兔激素性股骨头坏死股骨头局部过氧化物酶体增殖物激活受体的影响[J].中国骨伤,2012(5): 407-410.
[54] Xu YX, Wu CL, Wu Y, et al. Epimedium-derived flavonoids modulate the balance between osteogenic differentiation and adipogenic differentiation in bone marrow stromal cells of ovariectomized rats via Wnt/beta-catenin signal pathway activation. Chin J Integr Med. 2012;18(12):909-917. |